Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticholinergic Deprescription in Schizophrenia Spectrum
NCT06562608Phase 4Recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of benztropine, trihexyphenidyl in schizophrenia, schizoaffective disorder. Started Feb 2025; status: recruiting.
02
Drugs
benztropinetrihexyphenidyl
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT06562608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562608.